SGP
SpyGlass Pharma, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$815.94M
P/E Ratio
—
EPS
$-1.27
Beta
—
52W High
$32.44
52W Low
$20.15
50-Day MA
$25.10
200-Day MA
$25.57
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About SpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. (SGP) is at the forefront of biopharmaceutical innovation, dedicated to the development and commercialization of groundbreaking therapies targeting critical health conditions. With a diverse and promising pipeline, SGP is committed to leveraging cutting-edge technologies to fulfill unmet medical needs and improve patient outcomes. The company's strategic alliances enhance its competitive edge and support its growth strategies, positioning SGP as an attractive investment opportunity for institutional investors interested in the dynamic biopharmaceutical sector.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-40.84M |
| Operating Margin | 0.00% |
| Return on Equity | -67.70% |
| Return on Assets | -37.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-44.85 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $33.43M |
| Float | $6.48M |
| % Insiders | 42.84% |
| % Institutions | 81.09% |
Historical Volatility
HV 10-Day
44.83%
HV 20-Day
71.40%
HV 30-Day
87.16%
HV 60-Day
—
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026